Meet the team

Stuart Travers

COO & Board of Directors

Stuart Travers co-founded Sentinel in 2005 and is chief operating officer of Sentinel Oncology. Stuart has worked in the industry for over 25 years and has a successful track record in identifying drugs in multiple therapeutic areas. Stuart started his career in 1989 at Glaxo Group Research and since then has worked in a variety of small and large biotech organisations since 1997 in a number of senior scientific roles.